T1	tradename 110 115	Ontak
T3	tradename 177 183	Ontak.
T5	tradename 184 190	ONTAK"
T7	nanoparticle 193 213	denileukin diftitox)
T9	routeofadministration 228 239	intravenous
T11	fdaapprovaldate 272 276	1999
T13	adversereaction 286 312	SERIOUS INFUSION REACTIONS
T15	adversereaction 314 337	CAPILLARY LEAK SYNDROME
T17	adversereaction 342 364	LOSS OF VISUAL ACUITY.
T19	adversereaction 478 515	Serious and fatal infusion reactions.
T21	tradename 528 533	Ontak
T23	adversereaction 610 633	Capillary leak syndrome
T25	adversereaction 660 699	Loss of visual acuity and color vision.
T27	tradename 749 754	Ontak
T29	indication 829 949	persistent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor.
T31	co-administereddrug 1000 1013	antihistamine
T33	co-administereddrug 1018 1031	acetaminophen
T35	tradename 1046 1051	Ontak
T37	dose 1076 1089	9 or 18 mcg/g
T39	frequency 1089 1093	/day
T41	routeofadministration 1097 1108	intravenous
T43	duration 1144 1162	5 consecutive days
T45	frequency 1163 1176	every 21 days
T47	adversereaction 1352 1371	Infusion reactions:
T49	tradename 1417 1422	Ontak
T51	adversereaction 1427 1454	serious infusion reactions.
T53	adversereaction 1499 1523	Capillary leak syndrome:
T55	adversereaction 1594 1633	Loss of Visual Acuity and Color Vision:
T57	tradename 1803 1808	Ontak
T59	adversereaction 1929 1936	pyrexia
T61	adversereaction 1938 1944	nausea
T63	adversereaction 1945 1952	fatigue
T65	adversereaction 1955 1960	igors
T67	adversereaction 1962 1970	vomiting
T69	adversereaction 1972 1980	diarrhea
T71	adversereaction 1982 1990	headache
T73	adversereaction 1992 2008	peripheral edema
T75	adversereaction 2009 2014	cough
T77	adversereaction 2016 2023	dyspnea
T79	adversereaction 2028 2036	prurtus.
T81	company 2088 2098	Eisai Inc.
T83	adversereaction 2507 2533	SERIOUS INFUSION REACTIONS
T85	adversereaction 2535 2558	CAPILLARY LEAK SYNDROME
T87	adversereaction 2563 2585	LOSS OF VISUAL ACUITY.
T89	adversereaction 2792 2810	Infusion Reactions
T91	adversereaction 2815 2838	Capillary Leak Syndrome
T93	adversereaction 2843 2854	Visual Loss
T95	tradename 3573 3578	Ontak
T97	indication 3627 3745	peristent or recurrent cutaneous T-cell lymphoma whose malignant cells express the CD25 component of the IL-2 receptor
T99	co-administereddrug 3872 3885	antihistamine
T101	co-administereddrug 3890 3909	acetaminophen prior
T103	tradename 3918 3923	Ontak
T105	dose 3948 3960	9 or 18 mcgl
T107	frequency 3960 3964	/day
T109	routeofadministration 3968 3979	intravenous
T111	duration 4013 4031	5 consecutive days
T113	frequency 4032 4045	every 21 days
T115	tradename 4126 4131	Ontak
T117	tradename 4388 4393	Ontak
T119	tradename 4825 4830	Ontak
T121	tradename 4871 4876	Ontak
T123	tradename 4978 4983	Ontak
T125	tradename 5264 5270	Ontak.
T127	tradename 5283 5288	Ontak
T129	tradename 5325 5330	Ontak
T131	tradename 5392 5397	Ontak
T133	tradename 5480 5485	Ontak
T135	adversereaction 5662 5680	Infusion Reactions
T137	adversereaction 5682 5700	Infusion reactions
T139	tradename 5859 5872	Ontak-treated
T141	adversereaction 5951 5977	Serious infusion reactions
T143	tradename 6011 6024	Ontak-treated
T145	tradename 6161 6166	Ontak
T147	tradename 6331 6337	Ontak.
T149	tradename 6389 6394	Ontak
T151	tradename 6456 6461	Ontak
T153	adversereaction 6466 6493	serious infusion reactions.
T155	adversereaction 6499 6522	Capillary Leak Syndrome
T157	adversereaction 6523 6546	Capillary leak syndrome
T159	adversereaction 6622 6633	hypotension
T161	adversereaction 6635 6640	edema
T163	adversereaction 6642 6665	serum album -c3.0 g/dL)
T165	tradename 6685 6690	Ontak
T167	adversereaction 6780 6804	capillary leak syndrome.
T169	adversereaction 6817 6840	capillary leak syndrome
T171	tradename 6875 6888	Ontak-treated
T173	adversereaction 6929 6952	capillary leak syndrome
T175	adversereaction 7084 7107	capillary leak syndrome
T177	adversereaction 7168 7191	capillary leak syndrome
T179	tradename 7305 7311	Ontak.
T181	adversereaction 7379 7384	edema
T183	adversereaction 7386 7399	hypotension (
T185	tradename 7563 7568	Ontak
T187	adversereaction 7659 7670	Visual Loss
T189	adversereaction 7672 7693	Loss of visual acuity
T191	adversereaction 7708 7728	loss of color vision
T193	adversereaction 7746 7770	retinal pigment mottling
T195	tradename 7815 7821	Ontak.
T197	adversereaction 7921 7939	visual impairment.
T199	tradename 8065 8071	Ontak:
T201	tradename 8361 8366	Ontak
T203	adversereaction 8606 8624	Infusion Reactions
T205	adversereaction 8662 8685	Capillary Leak Syndrome
T207	tradename 9101 9106	Ontak
T209	dose 9110 9117	9 mcg/g
T211	dose 9128 9135	18mcg/g
T213	tradename 9248 9261	Ontak-treated
T215	dose 9302 9316	9 and 18 mcg/g
T217	dose 9377 9385	18 mcg/g
T219	tradename 9679 9684	Ontak
T221	adversereaction 9712 9719	pyrexia
T223	adversereaction 9721 9727	nausea
T225	adversereaction 9729 9736	fatigue
T227	adversereaction 9738 9744	rigors
T229	adversereaction 9746 9754	vomiting
T231	adversereaction 9756 9764	diarrhea
T233	adversereaction 9766 9774	headache
T235	adversereaction 9776 9792	peripheral edema
T237	adversereaction 9794 9799	cough
T239	adversereaction 9801 9808	dyspnea
T241	adversereaction 9813 9822	pruritus.
T243	adversereaction 9871 9894	capillary leak syndrome
T245	adversereaction 9903 9921	infusion reactions
T247	adversereaction 9959 9980	loss of visual acuity
T249	tradename 9987 9992	Ontak
T251	tradename 10115 10120	Ontak
T253	tradename 10279 10284	Ontak
T255	dose 10319 10326	9 mcg/g
T257	dose 10362 10370	18 mcg/g
T259	tradename 10594 10607	Ontak-treated
T261	dose 10618 10626	18 mcg/g
T263	tradename 10682 10693	Ontak Ontak
T265	dose 10707 10721	9mcg/g 18mcg/g
T267	adversereaction 10786 10792	Pyrxia
T269	adversereaction 10822 10828	Nausea
T271	adversereaction 10859 10865	Rigors
T273	adversereaction 10895 10902	Fatigue
T275	adversereaction 10933 10942	Vomitting
T277	adversereaction 10969 10977	Headache
T279	adversereaction 11008 11023	Edema perpheral
T281	adversereaction 11054 11062	Diarrhea
T283	adversereaction 11090 11098	Anorexia
T285	adversereaction 11125 11129	Rash
T287	adversereaction 11158 11165	Myalgia
T289	adversereaction 11195 11200	Cough
T291	adversereaction 11227 11235	Pruritus
T293	adversereaction 11265 11274	Back pain
T295	adversereaction 11304 11312	Asthenia
T297	adversereaction 11341 11352	Hypotension
T299	adversereaction 11379 11412	Upper respiratory tract infection
T301	adversereaction 11438 11446	Diziness
T303	adversereaction 11474 11484	Arthralgia
T305	adversereaction 11512 11516	Pain
T307	adversereaction 11543 11553	Chest pain
T309	adversereaction 11580 11589	Dysgeusia
T311	adversereaction 11613 11620	Dyspnea
T313	adversereaction 11674 11699	Increase in serum alanine
T315	adversereaction 11701 11753	aminotransferase (ALT) or aspartate aminotransferase
T317	adversereaction 11756 11761	(AST)
T319	tradename 11817 11822	Ontak
T321	tradename 12032 12038	Ontak.
T323	nanoparticle 12082 12101	denileukin diftitox
T325	nanoparticle 12218 12237	denileukin diftitox
T327	nanoparticle 12514 12532	denileukin difttox
T329	nanoparticle 12778 12798	denileukin diftitox.
T331	nanoparticle 13134 13153	denileukin diftitox
T333	nanoparticle 13295 13314	denileukin diftitox
T335	activeingredient 13399 13415	diphtheria toxin
T337	nanoparticle 13554 13573	denileukin diftitox
T339	dose 13617 13631	9 and 18 mcg/g
T341	frequency 13631 13635	/day
T343	auc 13754 13758	80%)
T345	tradename 14386 14392	Ontak.
T347	adversereaction 14614 14629	hyperthyroidism
T349	adversereaction 14631 14642	thyroiditis
T351	adversereaction 14644 14658	thyrotoxicosis
T353	adversereaction 14664 14679	hypothyroidism.
T355	tradename 14768 14774	Ontak.
T357	tradename 15008 15020	Ontak. Ontak
T359	tradename 15126 15131	Ontak
T361	tradename 15290 15295	Ontak
T363	tradename 15372 15377	Ontak
T365	tradename 15575 15580	Ontak
T367	dose 15782 15791	31 mcg/kg
T369	frequency 15791 15796	/day)
T371	adversereaction 15828 15834	nausea
T373	adversereaction 15836 15844	vomiting
T375	adversereaction 15846 15851	fever
T377	adversereaction 15853 15859	chills
T379	adversereaction 15867 15887	persistent asthenia.
T381	tradename 15906 15911	Ontak
T383	nanoparticle 15913 15933	denileukin diftitox)
T385	activeingredient 16023 16039	diphtheria toxin
T387	molecularweight 16216 16222	58 kD.
T389	tradename 16312 16317	Ontak
T391	routeofadministration 16393 16424	intravenous (IV) administration
T393	tradename 16445 16450	Ontak
T395	nanoparticle 16482 16501	denileukin diftitox
T397	inactiveingredient 16527 16538	citric acid
T399	inactiveingredient 16548 16552	EDTA
T401	inactiveingredient 16567 16581	polysorbate 20
T403	inactiveingredient 16594 16599	Water
T405	nanoparticle 16717 16736	Denileukin diftitox
T407	activeingredient 16800 16816	diphtheria toxin
T409	nanoparticle 16943 16962	denileukin diftitox
T411	activeingredient 17067 17083	diphtheria toxin
T413	nanoparticle 17287 17306	denileukin diftitox
T415	dose 17346 17357	3 to 31 mcg
T417	frequency 17357 17362	/day)
T419	indication 17380 17389	lymphoma.
T421	nanoparticle 17391 17410	Denileukin diftitox
T423	routeofadministration 17434 17436	IV
T425	nanoparticle 17525 17544	denileukin diftitox
T427	eliminationhalflife 17693 17710	70 to 80 minutes)
T429	clearance 17804 17822	0.6 to 2.0 mL/ming
T431	volumeofdistribution 17901 17919	0.06 to 0.09 L/kg)
T433	nanoparticle 18184 18204	denileukin diftitox.
T435	nanoparticle 18356 18396	denileukin diftitox. Denileukin diftitox
T437	nanoparticle 18539 18558	denileukin diftitox
T439	tradename 18698 18703	Ontak
T441	dose 19035 19036	0
T443	dose 19038 19052	9 or 18 mcg/kg
T445	frequency 19052 19056	/day
T447	tradename 19057 19062	Ontak
T449	routeofadministration 19067 19078	intravenous
T451	duration 19105 19113	21 day
T453	dose 19503 19509	9mcg/g
T455	frequency 19509 19513	/day
T457	tradename 19514 19520	Ontak.
T459	dose 19540 19548	18 mcg/g
T461	frequency 19548 19552	/day
T463	tradename 19553 19559	Ontak.
T465	dose 20632 20646	9 or l8 mcg/kg
T467	frequency 20646 20650	/day
T469	tradename 20987 20992	Ontak
T471	routeofadministration 21016 21018	iv
T473	frequency 21028 21033	daily
T475	duration 21038 21044	5 days
T477	frequency 21045 21059	every 3 weeks.
T479	tradename 21102 21107	Ontak
T481	tradename 21495 21500	Ontak
T483	dose 21960 21967	9 mcg/g
T485	frequency 21967 21971	/day
T487	dose 21972 21980	18 mcg/g
T489	frequency 21980 21984	/day
T491	tradename 22275 22280	Ontak
T493	adversereaction 22527 22532	Fever
T495	adversereaction 22534 22540	chills
T497	adversereaction 22542 22560	breathing problems
T499	adversereaction 22562 22572	chest pain
T501	adversereaction 22574 22585	tachycardia
T503	adversereaction 22591 22598	uricara
T505	adversereaction 22621 22638	Rapid weight gain
T507	adversereaction 22640 22645	edema
T509	adversereaction 22651 22684	orthostatic hypotension following
T511	adversereaction 22741 22752	Visual loss
T513	adversereaction 22754 22785	including loss of color vision.
T515	company 22821 22831	Eisai Inc.
